María Angélica Santana

María Angélica Santana

Auto-generated profile, based on publicly available information

María Angélica Santana

Centro de Investigación en Dinámica Celular (IICBA), Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2003 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MSM.A. Santana
M.A. Santana
YRY. Rosenstein
Y. Rosenstein

1 November 2016 in Cell Reports
Verified
Journal Article
Open access
AGAriel O. Galindo-Albarrán
Ariel O. Galindo-Albarrán
OLOscar H. López-Portales
Oscar H. López-Portales
DGDarely Y. Gutiérrez-Reyna
Darely Y. Gutiérrez-Reyna
OROtoniel Rodríguez-Jorge
Otoniel Rodríguez-Jorge
JSJosé Antonio Sánchez-Villanueva
José Antonio Sánchez-Villanueva
MSM. Angélica Santana
M. Angélica Santana
To better understand why human neonates show a poor response to intracellular pathogens, we compared gene expression and histone modification profiles of neonatal naive CD8+ T cells with that of their adult counterparts. We found that neonatal lymphocytes have a distinct epigenomic landscape associated with a lower expression of genes involved in T cell receptor (TCR) signaling and cytotoxicity and a higher expression of genes involved in the cell cycle and innate immunity. Functional studies corroborated that neonatal CD8+ T cells are less cytotoxic, transcribe antimicrobial peptides, and produce reactive oxygen species. Altogether, our results show that neonatal CD8+ T cells have a specific genetic program biased toward the innate immune response. These findings will contribute to better diagnosis and management of the neonatal immune response.

16 April 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
OROtoniel Rodríguez-Jorge
Otoniel Rodríguez-Jorge
LKLinda A. Kempis-Calanis
Linda A. Kempis-Calanis
WAWassim Abou-Jaoudé
Wassim Abou-Jaoudé
DGDarely Y. Gutiérrez-Reyna
Darely Y. Gutiérrez-Reyna
CHCéline Hernandez
Céline Hernandez
DTDenis Thieffry
Denis Thieffry
CD4+ T cells recognize antigens through their T cell receptors (TCRs); however, additional signals involving costimulatory receptors, for example, CD28, are required for proper T cell activation. Alternative costimulatory receptors have been proposed, including members of the Toll-like receptor (TLR) family, such as TLR5 and TLR2. To understand the molecular mechanism underlying a potential costimulatory role for TLR5, we generated detailed molecular maps and logical models for the TCR and TLR5 signaling pathways and a merged model for cross-interactions between the two pathways. Furthermore, we validated the resulting model by analyzing how T cells responded to the activation of these pathways alone or in combination, in terms of the activation of the transcriptional regulators CREB, AP-1 (c-Jun), and NF-κB (p65). Our merged model accurately predicted the experimental results, showing that the activation of TLR5 can play a similar role to that of CD28 activation with respect to AP-1, CREB, and NF-κB activation, thereby providing insights regarding the cross-regulation of these pathways in CD4+ T cells.

15 December 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
PCPierre Cauchy
Pierre Cauchy
MMMuhammad A. Maqbool
Muhammad A. Maqbool
JZJoaquin Zacarias-Cabeza
Joaquin Zacarias-Cabeza
LVLaurent Vanhille
Laurent Vanhille
FKFrederic Koch
Frederic Koch
JAJean-Christophe Andrau
Jean-Christophe Andrau
Ets1 is a sequence-specific transcription factor that plays an important role during hematopoiesis, and is essential for the transition of CD4−/CD8− double negative (DN) to CD4+/CD8+ double positive (DP) thymocytes. Using genome-wide and functional approaches, we investigated the binding properties, transcriptional role and chromatin environment of Ets1 during this transition. We found that while Ets1 binding at distal sites was associated with active genes at both DN and DP stages, its enhancer activity was attained at the DP stage, as reflected by levels of the core transcriptional hallmarks H3K4me1/3, RNA Polymerase II and eRNA. This dual, stage-specific ability reflected a switch from non-T hematopoietic toward T-cell specific gene expression programs during the DN-to-DP transition, as indicated by transcriptome analyses of Ets1−/− thymic cells. Coincidentally, Ets1 associates more specifically with Runx1 in DN and with TCF1 in DP cells. We also provide evidence that Ets1 predominantly binds distal nucleosome-occupied regions in DN and nucleosome-depleted regions in DP. Finally and importantly, we demonstrate that Ets1 induces chromatin remodeling by displacing H3K4me1-marked nucleosomes. Our results thus provide an original model whereby the ability of a transcription factor to bind nucleosomal DNA changes during differentiation with consequences on its cognate enhancer activity.

1 October 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MSM. Angélica Santana
M. Angélica Santana
GPGustavo Pedraza-Alva
Gustavo Pedraza-Alva
NONorma Olivares-Zavaleta
Norma Olivares-Zavaleta
VMVicente Madrid-Marina
Vicente Madrid-Marina
VHVaclav Horejsi
Vaclav Horejsi
YRYvonne Rosenstein
Yvonne Rosenstein
Although numerous reports document a role for CD43 in T cell signaling, the direct participation of this molecule in cell activation has been questioned. In this study we show that CD43 ligation on human normal peripheral T cells was sufficient to induce interleukin-2, CD69, and CD40-L gene expression, without requiring signals provided by additional receptor molecules. This response was partially inhibited by cyclosporin A and staurosporine, suggesting the participation of both the Ca(2+) and the protein kinase C pathways in CD43 signaling. Consistent with the transient CD43-dependent intracellular Ca(2+) peaks reported by others, signals generated through the CD43 molecule resulted in the induction of NF-AT DNA binding activity. CD43-dependent signals resulted also in AP-1 and NFkappaB activation, probably as a result of protein kinase C involvement. AP-1 complexes bound to the AP-1 sequence contained c-Jun, and those bound to the NF-AT-AP-1 composite site contained c-Jun and Fos. NFkappaB complexes containing p65 could be found as early as 1 h after CD43 cross-linking, suggesting that CD43 participates in early events of T cell activation. The induction of the interleukin-2, CD69, and CD-40L genes and the participation of AP-1, NF-AT, and NFkappaB in the CD43-mediated signaling cascade implicate an important role for this molecule in the regulation of gene expression and cell function.

1 January 2006
Verified
Book Chapter
Closed access
MSMaría Angélica Santana
María Angélica Santana
FEFERNANDO ESQUIVEL
FERNANDO ESQUIVEL